Goelzer Investment Management Inc. Has $357,000 Stock Position in CVS Health Corporation (NYSE:CVS)

Goelzer Investment Management Inc. trimmed its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 51.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,266 shares of the pharmacy operator's stock after selling 5,584 shares during the quarter. Goelzer Investment Management Inc.'s holdings in CVS Health were worth $357,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Hopwood Financial Services Inc. bought a new position in shares of CVS Health during the 4th quarter valued at $29,000. McIlrath & Eck LLC increased its position in CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the last quarter. MV Capital Management Inc. raised its holdings in CVS Health by 63.9% during the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock valued at $50,000 after buying an additional 289 shares in the last quarter. Dunhill Financial LLC boosted its stake in shares of CVS Health by 147.2% during the 1st quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock worth $51,000 after acquiring an additional 446 shares in the last quarter. Finally, Atwood & Palmer Inc. increased its holdings in shares of CVS Health by 228.0% during the 1st quarter. Atwood & Palmer Inc. now owns 820 shares of the pharmacy operator's stock valued at $56,000 after acquiring an additional 570 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.22% of the company's stock.

Analyst Ratings Changes

CVS has been the subject of a number of recent analyst reports. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Mizuho raised their target price on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Cowen reiterated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Robert W. Baird upped their price target on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Finally, Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $75.06.

CVS Health Stock Performance

Shares of NYSE:CVS traded up $0.78 during trading on Friday, hitting $67.38. 3,770,987 shares of the stock were exchanged, compared to its average volume of 10,832,881. The company has a market capitalization of $85.23 billion, a price-to-earnings ratio of 16.08, a price-to-earnings-growth ratio of 0.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The company's fifty day simple moving average is $65.06 and its 200-day simple moving average is $61.31.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter in the previous year, the company earned $1.31 earnings per share. The business's revenue was up 7.0% compared to the same quarter last year. Sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.